117 related articles for article (PubMed ID: 24388586)
1. Pyrosequencing reveals an oseltamivir-resistant marker in the quasispecies of avian influenza A (H7N9) virus.
Mok CK; Chang SC; Chen GW; Lo YL; Chen SJ; Wu HS; Liu MT; Chang FY; Lin TY; Shih SR
J Microbiol Immunol Infect; 2015 Aug; 48(4):465-9. PubMed ID: 24388586
[TBL] [Abstract][Full Text] [Related]
2. Virological, serological, and antiviral studies in an imported human case of avian influenza A(H7N9) virus in Taiwan.
Lin PH; Chao TL; Kuo SW; Wang JT; Hung CC; Lin HC; Yang ZY; Ho SY; Chang CK; Huang MS; Chen HH; Chen YC; Lai HS; Chang SY; Chang SC; Yang PC
Clin Infect Dis; 2014 Jan; 58(2):242-6. PubMed ID: 24076969
[TBL] [Abstract][Full Text] [Related]
3. Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R/K viral population.
Yen HL; McKimm-Breschkin JL; Choy KT; Wong DD; Cheung PP; Zhou J; Ng IH; Zhu H; Webby RJ; Guan Y; Webster RG; Peiris JS
mBio; 2013 Jul; 4(4):. PubMed ID: 23860768
[TBL] [Abstract][Full Text] [Related]
4. A novel pyrosequencing assay for the detection of neuraminidase inhibitor resistance-conferring mutations among clinical isolates of avian H7N9 influenza virus.
Qi Y; Fan H; Qi X; Zhu Z; Guo X; Chen Y; Ge Y; Zhao K; Wu T; Li Y; Shan Y; Zhou M; Shi Z; Wang H; Cui L
Virus Res; 2014 Jan; 179():119-24. PubMed ID: 24211668
[TBL] [Abstract][Full Text] [Related]
5. [Drug susceptibility of wild-type and mutant H7N9 neuraminidase to zanamivir and oseltamivir].
Wei YN; Zhang C; Chen Q; Guo Y
Bing Du Xue Bao; 2014 Jul; 30(4):396-401. PubMed ID: 25272593
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time reverse transcriptase PCR.
Hindiyeh M; Ram D; Mandelboim M; Meningher T; Hirsh S; Robinov J; Levy V; Orzitzer S; Azar R; Grossman Z; Mendelson E
J Clin Microbiol; 2010 May; 48(5):1884-7. PubMed ID: 20220153
[TBL] [Abstract][Full Text] [Related]
7. Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.
Marjuki H; Mishin VP; Chesnokov AP; Jones J; De La Cruz JA; Sleeman K; Tamura D; Nguyen HT; Wu HS; Chang FY; Liu MT; Fry AM; Cox NJ; Villanueva JM; Davis CT; Gubareva LV
J Infect Dis; 2015 Jan; 211(2):249-57. PubMed ID: 25124927
[TBL] [Abstract][Full Text] [Related]
8. PCR for detection of oseltamivir resistance mutation in influenza A(H7N9) virus.
Wang W; Song Z; Guan W; Liu Y; Zhang X; Xu L; Li J; Yuan Z; Hu Y
Emerg Infect Dis; 2014 May; 20(5):847-9. PubMed ID: 24751348
[TBL] [Abstract][Full Text] [Related]
9. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility.
Hai R; Schmolke M; Leyva-Grado VH; Thangavel RR; Margine I; Jaffe EL; Krammer F; Solórzano A; García-Sastre A; Palese P; Bouvier NM
Nat Commun; 2013; 4():2854. PubMed ID: 24326875
[TBL] [Abstract][Full Text] [Related]
10. Allele-specific conventional reverse-transcription polymerase chain reaction as a screening assay for discriminating influenza a H1N1 (H275Y) oseltamivir-resistant and wild-type viruses.
Ngai KL; Lam WY; Lee N; Leung TF; Hui DS; Chan PK
J Med Virol; 2010 Aug; 82(8):1295-8. PubMed ID: 20572070
[TBL] [Abstract][Full Text] [Related]
11. Rapid genotypic assay for detection of oseltamivir-resistant influenza A (H1N1) viruses.
Hata M; Tanaka S; Yasui Y; Fujiwara N; Kobayashi S; Minagawa H
J Clin Microbiol; 2010 May; 48(5):1983-4. PubMed ID: 20220172
[No Abstract] [Full Text] [Related]
12. Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.
Marjuki H; Mishin VP; Chesnokov AP; De La Cruz JA; Davis CT; Villanueva JM; Fry AM; Gubareva LV
J Virol; 2015 May; 89(10):5419-26. PubMed ID: 25740997
[TBL] [Abstract][Full Text] [Related]
13. Host immunological response and factors associated with clinical outcome in patients with the novel influenza A H7N9 infection.
Shen Z; Chen Z; Li X; Xu L; Guan W; Cao Y; Hu Y; Zhang J
Clin Microbiol Infect; 2014 Aug; 20(8):O493-500. PubMed ID: 24350809
[TBL] [Abstract][Full Text] [Related]
14. Characterization of viral genomic mutations in novel influenza A (H7N9)-infected patients: the association between oseltamivir-resistant variants and viral shedding duration.
Chen R; Zou Q; Xie G; Yu F; Yang X; Cao L; Huo Z; Zheng S
Virus Genes; 2019 Oct; 55(5):592-599. PubMed ID: 31302878
[TBL] [Abstract][Full Text] [Related]
15. Profile and generation of reduced neuraminidase inhibitor susceptibility in highly pathogenic avian influenza H7N9 virus from human cases in Mainland of China, 2016-2019.
Tang J; Zhang SX; Zhang J; Li XY; Zhou JF; Zou SM; Bo H; Xin L; Yang L; Liu J; Huang WJ; Dong J; Wang DY
Virology; 2020 Oct; 549():77-84. PubMed ID: 32853849
[TBL] [Abstract][Full Text] [Related]
16. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
[TBL] [Abstract][Full Text] [Related]
17. The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay.
Chidlow GR; Harnett GB; Williams SH; Tempone SS; Speers DJ; Hurt AC; Deng YM; Smith DW
J Virol Methods; 2010 Oct; 169(1):47-51. PubMed ID: 20600329
[TBL] [Abstract][Full Text] [Related]
18. Substitution of I222L-E119V in neuraminidase from highly pathogenic avian influenza H7N9 virus exhibited synergistic resistance effect to oseltamivir in mice.
Tang J; Gao R; Liu L; Zhang S; Liu J; Li X; Fang Q; Feng Z; Xu C; Huang W; Wang D
Sci Rep; 2021 Aug; 11(1):16293. PubMed ID: 34381119
[TBL] [Abstract][Full Text] [Related]
19. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
[TBL] [Abstract][Full Text] [Related]
20. Reverse-transcription polymerase chain reaction/pyrosequencing to characterize neuraminidase H275 residue of influenza A 2009 H1N1 virus for rapid and specific detection of the viral oseltamivir resistance marker in a clinical laboratory.
Bao JR; Huard TK; Piscitelli AE; Tummala PR; Aleemi VE; Coon SL; Master RN; Lewinski MA; Clark RB
Diagn Microbiol Infect Dis; 2011 Dec; 71(4):396-402. PubMed ID: 22000086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
